(Q35868862)

English

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis

scientific article published on 7 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

selective reduction

1 reference

based on heuristic

inferred from title

Michelle A Lowes

object named as

Michelle A Lowes

12

0 references

James G. Krueger

11

object named as

James G Krueger

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Francesca Chamian

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Shao-Lee Lin

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Edmund Lee

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Toyoko Kikuchi

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Patricia Gilleaudeau

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Mary Sullivan-Whalen

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Irma Cardinale

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Artemis Khatcherian

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Inna Novitskaya

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Knut M Wittkowski

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

7 June 2007

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

27

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Central memory and effector memory T cell subsets: function, generation, and maintenance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

The aging of the immune system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

The immunologic basis for the treatment of psoriasis with new biologic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

CD2 sets quantitative thresholds in T cell activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

11 July 2018

Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

24 September 2018

CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

24 September 2018

Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

24 September 2018

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

24 September 2018

Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906741

22 October 2018

CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating CD2+ monocytes are dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-5-27

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35868862&oldid=2197889042"